TOYA Yoshiyuki

J-GLOBAL         Last updated: Feb 22, 2017 at 14:54
TOYA Yoshiyuki

Research Interests


Research Areas



Faculty of Medicine, Yokohama City University


Atherosclerosis   240 297-304   May 2015
© 2015 The Authors. There is no clinical evidence that supports the benefit of integrative medicine, defined as combination therapy of oriental and western medicine, on obesity-related hypertension. This study evaluates the efficacy of Bofu-tsusho...
Clinical and Experimental Nephrology   19 240-246   Apr 2015
© 2014, The Author(s). Background: Cyclosporine and prednisolone combination therapy has been used in the treatment of minimal change nephrotic syndrome (MCNS). However, few studies have evaluated the efficacy of cyclosporine combined with intrave...
Therapeutic Apheresis and Dialysis   19 131-137   Jan 2015
© 2014 International Society for Apheresis. This study aimed to evaluate the effect of different timings of iron administration during erythropoiesis activated by continuous erythropoietin receptor activator (CERA) on reticulocyte iron uptake in h...
Clinical and Experimental Hypertension   36 244-250   Jan 2014
Diuretics or calcium channel blockers (CCBs) are used concomitantly with an angiotensin II receptor blocker (ARB). However, it is not established which ARB-based combination therapy is the most effective and safe. This prospective randomized open-...
Therapeutic Apheresis and Dialysis   18 421-426   Jan 2014
© 2014 International Society for Apheresis. Inadequate iron availability limits the response to erythropoiesis-stimulating agents (ESA) and hepcidin is a key regulator of iron metabolism. However, there is little information concerning time-depend...

Research Grants & Projects

Study of signal trunsduction system